Insider Transactions in Q1 2023 at International Flavors & Fragrances Inc (IFF)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Frank Clyburn Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-36.05%
|
$43,407
$91.64 P/Share
|
|
Mar 01
2023
|
Frank Clyburn Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,323
+50.0%
|
-
|
|
Feb 19
2023
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-6.22%
|
$28,128
$96.13 P/Share
|
|
Feb 19
2023
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
708
+13.07%
|
-
|
|
Feb 19
2023
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-2.81%
|
$16,896
$96.13 P/Share
|
|
Feb 19
2023
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
584
+8.54%
|
-
|
|
Feb 19
2023
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
177
-3.19%
|
$16,992
$96.13 P/Share
|
|
Feb 19
2023
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
617
+10.01%
|
-
|
|
Jan 24
2023
|
Michael L Ducker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+18.28%
|
-
|
|
Jan 03
2023
|
De Villeplee Christophe Fauchon President, Scent |
BUY
Exercise of conversion of derivative security
|
Direct |
784
+8.04%
|
-
|
|
Jan 03
2023
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,229
-9.91%
|
$229,587
$103.11 P/Share
|
|
Jan 03
2023
|
Francisco Fortanet EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,254
+18.94%
|
-
|
|
Jan 03
2023
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
487
-7.91%
|
$51,135
$105.64 P/Share
|
|
Jan 03
2023
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
1,341
+17.89%
|
-
|